Abstract:Gallbladder carcinoma (GBC) is an aggressive malignancy with high mortality, mainly due to the reduced chance of curative resection and the resistance to chemotherapeutic drugs. Here, we showed that cellular Fas-associated death domain-like interleukin-1 converting enzyme inhibitory protein (c-FLIP), an antiapoptotic protein, was over-expressed in the most of gallbladder carcinoma tissues, as judged by immunohistochemistry. Semi-quantitation was performed by determining the percentage of c-FLIP-positive cells: no positive cells (-), similar to 1% positive cells (+), similar to 30% positive cells (++), and > 70% positive cells (+++). Out of the 35 tissue specimens of gallbladder carcinoma, positive c-FLIP expression was found in 26 samples (6/positive+++, 13/++, 7/+), whereas negative or weak c-FLIP staining was detected in normal (1/+, 9/-) and adenomatous (2/+, 8/-) gallbladder tissues. Then, we used a small interference RNA (siRNA), which can substantially down-regulate the expression levels of c-FLIP mRNA and protein in GBC-SD and SGC-996 human gallbladder carcinoma cells, as confirmed by real-time PCR and western blot analyses. Furthermore, the combined treatment with the c-FLIP siRNA and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) significantly induced apoptosis in gallbladder carcinoma cells, as judged by the increases in pyknosis, caspase-3/7 activities, and Annexin V-propidium iodide labeling, a marker for chromatin condensation. Thus, the siRNA-mediated down-regulation of c-FLIP profoundly enhances the sensitivity to TRAIL-induced apoptosis. In conclusion, c-FLIP expression is up-regulated in gallbladder carcinoma and the down-regulation of c-FLIP sensitizes TRAIL-induced apoptosis. The present study provides a potent strategy for the treatment of gallbladder carcinoma by targeting the c-FLIP.

fas si wang shou ti ji flip dui da chang ai xi bao diao wang de ying xiang

Suppression of Tumor Cell Immune Counterattack by Blocking FasL Expression in Pancreatic Cancer Cells

Fas/FasL and survivin expression in colorectal cancer cells after preoperative chemotherapy

Fas-mediated Pathway and Apoptosis in Normal Cervix, Cervical Intraepithelial Neoplasia and Cervical Squamous Cancer.

[The Correlation Between DNA Content and Fas Antigen in Non-Small Cell Lung Cancer].

The role of tumor infiltrating lymphocytes in colon caner cell lysis

Fas Ligand Expression in Colon Cancer: A Possible Mechanism of Tumor Immune Privilege

The Fas Expression in Gastric Cancer Cells and Peripheral Lymphocytes

Effect of intra-arterial infusion chemotherapy on expressions of Bcl-2 and Fas proteins in lung cancer

Correlative Studies Between DNA Content and Metastasis Associate Gene Expression in Patient with Non-Small Cell Lung Canner

The clinical studies of expressions of Fas, P-gp and mdr1 and their correlations in acute leukemia and MDR

Expression Level of FAF1 and the Relationship Between FAF1 Expression and the Apoptosis in Gastric Cancer

Expression of C-Flip in Malignant Melanoma, and Its Relationship with the Clinicopathological Features of the Disease

[The influence of FasL gene expression upon hepatic metastasis of colorectal carcinoma]

Expression of c-FLIP in breast cancer tissues and its relationship with the prognosis of breast cancer patients

Cervical carcinoma cell apoptosis and the expression of Fas and Fas ligand in human

The autophagic cell death in hepatcellular carcinoma cell lines with different metastatic potentials

Over-expression of c-FLIP confers the resistance to TRAIL-induced apoptosis on gallbladder carcinoma.

Expression profile of apoptosis pathway-specific genes of prostate cancer cells and different apoptosis susceptibility

[Detection of Cell Apoptosis Induced with Anti-Fas Antibody in Bladder Carcinoma Cell Line by Single Cell Gel Electrophoresis].

Expression of FLIP in Human Colon Carcinomas: A New Mechanism of Immune Evasion